London: A correlation between a first dose of the AstraZeneca vaccine and a small but significant rise in cases of the serious neurological condition Guillain-Barre syndrome (GBS), has been identified. Researchers at the University College London (UCL) said they are yet to understand the cause of the link. However, they noted that the small numbers […]
The study, published in the journal Brain, have found no significant association between Covid-19 and the potentially paralysing and sometimes fatal neurological condition Guillain-Barre syndrome.
While there have been several reports of Guillain-Barre Syndrome following Covid-19, this is the first in which Covid-19 actually triggered a recurrence of the condition.
